On Thursday, March 28 we hosted an educational dinner with CSL Behring at the Hilton Garden Inn in Bangor, ME. During the event, attendees learned more about HEMGENIX–the first and only gene therapy that is currently approved for hemophilia B.

The speaker was Guy Young, MD. Dr. Young is the Director of the Hemostasis and Thrombosis Center and the Clinical Coagulation Laboratory at Children’s Hospital Los Angeles and a Professor of Pediatrics at the University of Southern California Keck School of Medicine.

Disclaimer

This event is a paid advertisement and does not constitute an endorsement or recommendation from the New England Hemophilia Association (NEHA). The information presented during this event is provided for your general information only. NEHA does not give medical advice or engage in the practice of medicine. NEHA, under no circumstances, recommends particular treatment options for specific individuals, and, in all cases, recommends that you consult your physician or local treatment center before pursuing any course of treatment.

Event Sponsors

We are thankful to these companies for supporting this event: